# Solstice Oncology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/solstice-oncology

- Industry: Biotechnology
- Headquarters: Boston, US
- Total disclosed funding: $121M
- Latest round: Series A (Feb 20, 2026)
- Investors on record: 3

## About

Founded in 2026 and based in Massachusetts, Solstice Oncology is a clinical-stage immuno-oncology company developing cancer therapies for use before surgery for targeting colon cancer and other early-stage solid tumors.

## Funding rounds

- Series A, Feb 20, 2026, $121M — Canaan Partners, Forbion, RA Capital Management

## Investors

- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A
- Forbion (https://capitalatlas.ai/funds/forbion) — Series A
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series A